Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2012
04/19/2012WO2011119939A3 Manipulation of calcium channels to regulate after-depolarization events in cardiac myocytes
04/19/2012WO2011116396A3 Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
04/19/2012WO2011073234A3 Dry growth hormone composition transiently linked to a polymer carrier
04/19/2012US20120095558 Synthetic bone grafts constructed from carbon foam materials
04/19/2012US20120095518 Bone cement formula and bioresorbable hardened bone cement composites prepared with the same
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094937 Mammalian cell surface antigens; related reagents
04/19/2012US20120094936 MalPEG-Hb Conjugate-Containing Compositions for Delivering Nitric Oxide (NO) to Cells
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094933 Derivatives of apf and methods of use
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094931 Compositions and methods to modulate progression and onset of inflammatory bowel disease
04/19/2012US20120094930 Compounds for enzyme inhibition
04/19/2012US20120094929 Compounds for enzyme inhibition
04/19/2012US20120094928 Compounds for enzyme inhibition
04/19/2012US20120094927 Therapy for mll-rearranged leukemia
04/19/2012US20120094926 Compounds for enzyme inhibition
04/19/2012US20120094925 Insulin-like growth factor binding protein 7 for treatment of cancer
04/19/2012US20120094924 Nucleic acid delivery compounds
04/19/2012US20120094923 Methods and materials for assessing prostate cancer recurrence and reducing mesotrypsin activity
04/19/2012US20120094922 Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activity
04/19/2012US20120094921 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate
04/19/2012US20120094920 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094917 Iap inhibitors
04/19/2012US20120094916 Altering memory by affecting staufen function
04/19/2012US20120094915 Anti-mental fatigue drug
04/19/2012US20120094914 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases
04/19/2012US20120094913 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
04/19/2012US20120094912 MalPEG-Hb Conjugate-Containing Compositions for Delivering Carbon Monoxide (CO) to Cells
04/19/2012US20120094911 Endokinin c/d-derived peptides
04/19/2012US20120094910 Improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
04/19/2012US20120094909 Fibronectin based scaffold domain proteins that bind to pcsk9
04/19/2012US20120094908 Truncated activin type ii receptor and methods of use
04/19/2012US20120094907 Peptide therapy for increasing platelet levels
04/19/2012US20120094906 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
04/19/2012US20120094905 Method for Treating Hyperglycemia with GLP-1
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094903 Compositions for intranasal delivery of human insulin and uses thereof
04/19/2012US20120094902 Fast-acting insulin formulation
04/19/2012US20120094901 Method for controlling the digestive coagulation of proteins
04/19/2012US20120094900 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
04/19/2012US20120094899 Neuromedin u derivative
04/19/2012US20120094898 Peptide derivative
04/19/2012US20120094897 Novel inhibitors of hepatitis c virus replication
04/19/2012US20120094896 Inhibitors of viral integrase and methods of use
04/19/2012US20120094895 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
04/19/2012US20120094894 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
04/19/2012US20120093929 Opioid Composition for Treating Skin Lesions
04/19/2012US20120093920 Method of treatment for bladder dysfunction
04/19/2012US20120093919 E2f as a target of hormone refractory prostate cancer
04/19/2012US20120093917 Metnase and intnase inhibitors and their use in treating cancer
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/19/2012US20120093894 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
04/19/2012US20120093893 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
04/19/2012US20120093886 Pharmaceutical compositions and related methods of delivery
04/19/2012US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
04/19/2012US20120093881 Disruptive polymer micelle composition
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093866 Formulation for stabilizing proteins, which is free of mammalian excipient
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093849 Agents for Treatment of HCV and Methods of Use
04/19/2012US20120093844 Antimicrobial peptides based on cmap27
04/19/2012US20120093843 Tem8 peptides and vaccines comprising the same
04/19/2012US20120093842 Chimeric receptor genes and cells transformed therewith
04/19/2012US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
04/19/2012US20120093836 Pharmaceutical compositions for treating metastasis
04/19/2012US20120093831 Methods and materials for modulating resistance to apoptosis
04/19/2012US20120093822 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
04/19/2012US20120093816 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
04/19/2012US20120093815 Fgf21 mutants and uses thereof
04/19/2012US20120093803 Means and methods of sterilization of biofunctional compositions
04/19/2012US20120093802 Bioactive composition including stabilized protein and process for producing the same
04/19/2012US20120093801 Targeted delivery of therapeutic agents with lyophilized matrices
04/19/2012US20120093799 Recombinantly modified plasmin
04/19/2012US20120093798 Methods for Treatment of Stroke or Cerebrovascular
04/19/2012US20120093797 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093795 Compounds targeting the cation-independent mannose 6-phosphate receptor
04/19/2012US20120093794 Methods for Treating Pompe Disease
04/19/2012US20120093788 Protease for wound conditioning and skin care
04/19/2012US20120093784 Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation
04/19/2012US20120093776 Methods for treating diseases using a bone morphogenetic protein
04/19/2012US20120093775 Methods and compositions for the treatment of cirrhosis and liver fibrosis
04/19/2012US20120093771 Method for preparing a hardened calcium sulfate dihydrate block and use thereof
04/19/2012US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
04/19/2012US20120093769 Stem Cell Targeting with Dock-and-Lock (DNL) Complexes
04/19/2012US20120093768 Anti-connexin compounds targeted to connexins and methods of use thereof
04/19/2012US20120093767 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093766 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093765 Process for purification of recombinant human granulocyte colony stimulating factor
04/19/2012US20120093764 Treatment of diabetes using g-csf and hyperbaric oxygen
04/19/2012US20120093740 Peptide fragments for inducing synthesis of extracellular matrix proteins
04/19/2012US20120093738 Taste-masked oral formulations of influenza antivirals
1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 3163